![\"G\u00e9n\u00e9thon](\"https:\/\/www.institut-biotherapies.fr\/wp-content\/uploads\/2012\/08\/image-genethon-2-420x280.jpg\" "\\"G\u00e9n\u00e9thon")
<\/a><\/h2>\nGenethon has a bioproduction centre, Genethon Bioprod, which from 2012 will offer a production capacity of gene therapy products of a clinical grade never achieved. Its mission: produce gene therapy treatments for clinical trials conducted in France or abroad with the strictest compliance to regulatory requirements of pharmaceutical products.<\/p>\n
\n- Genethon Bioprod in figures<\/strong><\/li>\n<\/ul>\n
– 5000 m2<\/strong> dedicated to the bioproduction and control of gene therapy products including 4 production suites totalling 500 m2<\/p>\n– Production of 20 clinical batches per year<\/strong> at full capacity<\/p>\n– Up to 800 litres of culture in bioreactors<\/strong> for AAV type products (4 bioreactors of 200 litres)<\/p>\n– Up to 100 litres of culture<\/strong> for lentivirus type vectors<\/p>\nGenoSafe: evaluation of the efficacy and safety of biotherapeutic products<\/h2>\n
Created by the AFM-Telethon and Genethon, GenoSafe is a services company specialised in the evaluation of the efficacy and safety of biotherapeutic products<\/strong>.<\/p>\nFrom the different research stages to clinical studies, GenoSafe offers support in study design, development and validation of trials, in compliance with regulatory requirements.<\/p>\n","protected":false},"excerpt":{"rendered":"
The Biotherapies Institute has privileged access to two structures, bioproduction and quality control, essential to successfully carry out the clinical development of innovative therapies. Genethon Bioprod: production of viral vectors to GMP standards Genethon has a bioproduction centre, Genethon Bioprod, which from 2012 will offer a production capacity of gene therapy products of a clinical … [Read more]<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":2997,"menu_order":80,"comment_status":"closed","ping_status":"closed","template":"page-sidecolumn.php","meta":{"footnotes":""},"class_list":["post-4150","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/4150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=4150"}],"version-history":[{"count":0,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/4150\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/2997"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=4150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
– 5000 m2<\/strong> dedicated to the bioproduction and control of gene therapy products including 4 production suites totalling 500 m2<\/p>\n – Production of 20 clinical batches per year<\/strong> at full capacity<\/p>\n – Up to 800 litres of culture in bioreactors<\/strong> for AAV type products (4 bioreactors of 200 litres)<\/p>\n – Up to 100 litres of culture<\/strong> for lentivirus type vectors<\/p>\n Created by the AFM-Telethon and Genethon, GenoSafe is a services company specialised in the evaluation of the efficacy and safety of biotherapeutic products<\/strong>.<\/p>\n From the different research stages to clinical studies, GenoSafe offers support in study design, development and validation of trials, in compliance with regulatory requirements.<\/p>\n","protected":false},"excerpt":{"rendered":" The Biotherapies Institute has privileged access to two structures, bioproduction and quality control, essential to successfully carry out the clinical development of innovative therapies. Genethon Bioprod: production of viral vectors to GMP standards Genethon has a bioproduction centre, Genethon Bioprod, which from 2012 will offer a production capacity of gene therapy products of a clinical … [Read more]<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":2997,"menu_order":80,"comment_status":"closed","ping_status":"closed","template":"page-sidecolumn.php","meta":{"footnotes":""},"class_list":["post-4150","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/4150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=4150"}],"version-history":[{"count":0,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/4150\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/pages\/2997"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=4150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}GenoSafe: evaluation of the efficacy and safety of biotherapeutic products<\/h2>\n